Canada: Patent

Subscribe

Intellectual property law and copyright law thought leadership, articles, podcasts, videos and webinars from expert sources across the legal world. Explore insights covering topics such as licensing and syndication, patent law, trade secrets and trademark law.

How Canadian Businesses Can Protect Intellectual Property In Asia: A Legal Guide

Expanding into Asia offers Canadian businesses enormous potential—but it also exposes them to serious intellectual property (IP) risks.

BC

Brunet & Co

The Semaglutide Story: Highlighting The Need To Maintain Patent Protection In Canada

Semaglutide, the blockbuster GLP-1 receptor agonist marketed under names like Ozempic® (type 2 diabetes) and Wegovy® (weight loss), has rapidly become one of the most consequential drugs in modern healthcare.

BC

Brunet & Co

Canada vs. Asia: Key Differences In Intellectual Property Laws You Must Know

In today's global economy, businesses, entrepreneurs, and creatives frequently operate across borders.

BC

Brunet & Co

Why Canada Is On The USA IP Watch List?

The U.S. Special 301 Report is an annual review conducted by the Office of the United States Trade Representative (USTR) that evaluates the intellectual property (IP) protection and enforcement practices of U.S. trading partners.

BC

Brunet & Co

IP Basics: Trade Secrets (Podcast)

European Union IP

GW

Gowling WLG

Draft Regulations Aim To Strengthen, Clarify And Simplify Canada's Plant Breeders' Rights System

BL

Borden Ladner Gervais LLP

Cultural Heritage And Sustainability As Intellectual Property Assets

GW

Gowling WLG

Could IP Ownership Of The Human Cell Atlas Turn Into A Legal Headache For Researchers?

GW

Gowling WLG

Canada And The U.S.: Differences In Patent Prosecution

GW

Gowling WLG

IP Basics: Patent Enforcement (Podcast)

European Union IP

GW

Gowling WLG

The Role Of Intellectual Property In The Nuclear Sector

GW

Gowling WLG

No Cherry Picking Here: Canadian Cherry Patent Victory In U.S. Agribusiness Intellectual Property Case

F

Fasken

IP Basics: Patent Transactions (Podcast)

GW

Gowling WLG

Canadian Intellectual Property Office "Next Generation Patents" Update And Status As Of July 22, 2025

SB

Smart & Biggar

The Havoc Of The "Standard" Release In Employment Law And Human Rights

Canada Employment

BR

Bow River Law

Webinar: 2025 Global In-House Counsel Survey Report: Unique Insights Into The Global In-House Counsel Profession

Worldwide Law Practice

IC

In-House Counsel Worldwide

A Big Beautiful Betrayal For US Expats. Is Renunciation Of US Citizenship Now The Best (And Only) Option?

MP

Moodys Private Client Law LLP

BC Hydro Doubles Down: 2025 Call For Power Continues Clean Energy Push

ML

McMillan LLP

Ontario Court Comments On AI Competency

Canada Technology

MT

McCarthy Tétrault LLP

Forum Shopping Considerations For IP Litigation In Canada

When it comes to intellectual property (IP) litigation in Canada, most suits can be brought in either the Federal or provincial courts.

BD

Burnet, Duckworth & Palmer LLP

Aperçu du rapport statistique 2024-2025 de Santé Canada sur le régime canadien des brevets pharmaceutiques

Le 25 juillet 2025, Santé Canada a publié son rapport statistique annuel 2024-2025 sur le Règlement sur les médicaments brevetés (avis de conformité), la protection des données et les certificats de protection supplémentaire.

MT

McCarthy Tétrault LLP

IP Basics: An Introduction To Patents (Podcast)

In the first episode of our IP Basics Patent podcast series, Nick Cunningham, Of Counsel, and Megan Wiggin, Trainee Solicitor, explore the foundational principles of patents...

GW

Gowling WLG

Insights From Health Canada's 2024–2025 Statistical Report On Canadian Pharmaceutical Patent Regime

On July 25, 2025, Health Canada released its annual 2024–2025 Statistical Report for the Patented Medicines (Notice of Compliance) Regulations, Data Protection...

MT

McCarthy Tétrault LLP

Federal Court Decision Dismisses Patent Infringement Action

OW

Oyen Wiggs Green & Mutala LLP

Patented Drug Pricing: The PMPRB Releases New Price-Review Guidelines

C

Cassels

Licensing vs. Franchising: Understanding The Difference In Ontario

Pacific Legal PC

Patented Medicine Prices Review Board Publishes New Guidelines For PMPRB Staff: Finally, Some Guidance For Patentees

BL

Borden Ladner Gervais LLP

Previewing The Supreme Court Of Canada's Upcoming Hearing On The Patentability Of Methods Of Medical Treatment

GW

Gowling WLG

Crisp Boundaries: Federal Court Defines The Scope Of Protection For French Fry Manufacturing Process Patent

SB

Smart & Biggar

The High Cost Of Fashion Dupes: Trademark And Design Infringement And A View From The North

G

Gilbert's LLP

Compelling Third-Party Disclosure: The Power Of Norwich Orders

Canada Litigation

ML

McKercher LLP

Patents And Prior Art: Federal Court Clarifies Standards For Anticipation And Obviousness

AB

Aird & Berlis LLP

2025 Mid-year Highlights In Canadian Life Sciences IP And Regulatory Law

Canada Healthcare

SB

Smart & Biggar

The High Cost Of Fashion Dupes: Trademark And Design Infringement And A View From The North

Lululemon Athletica recently filed a lawsuit against Costco Wholesale in the US, alleging extensive intellectual property infringement involving trademarks, trade dress, and design patents.

G

Gilbert's LLP

Compelling Third-Party Disclosure: The Power Of Norwich Orders

People often find themselves in a situation where they have been wronged and want to seek legal recourse but struggle to identify the wrongdoer, locate evidence they need, or even trace money that was taken from them.

Canada Litigation

ML

McKercher LLP

Patents And Prior Art: Federal Court Clarifies Standards For Anticipation And Obviousness

The Federal Court's recent decision in Alexion Pharmaceuticals, Inc. v. Amgen Canada Inc. (2025 FC 754) offers important guidance on the use of prior art for anticipation arguments in patent validity.

AB

Aird & Berlis LLP

2025 Mid-year Highlights In Canadian Life Sciences IP And Regulatory Law

In the first half of 2025, the Rx IP Update team reported on a number of developments in Canadian life sciences IP and regulatory law. Below are our top stories.

Canada Healthcare

SB

Smart & Biggar

Important New Procedural Guidelines From The PMPRB

AM

Aird & McBurney LP

CDA Opens Consultation On Proposed List Of Drugs To Inform Development Of National Formulary

On June 19, 2025, Canada's Drug Agency (CDA) opened a public consultation on a proposed process for preparing a list of essential prescription drugs and related products.

Canada Healthcare

SB

Smart & Biggar

Do Not Wait On Enforcing Your Patent Rights – How Conflicting Statutory Limitation Periods May Complicate Your Lawsuit

Patentees and licensors should enforce their patent rights as quickly as they can to avoid possible issues of conflicting limitation periods.

OW

Oyen Wiggs Green & Mutala LLP

Key Differences In IP Litigation Between Canada And The United States

For companies and counsel navigating intellectual property enforcement across borders, it's critical to understand how litigation strategies vary between jurisdictions.

BD

Burnet, Duckworth & Palmer LLP

Canadian Patent Appeal Board Says AI Cannot Be An Inventor

The Patent Appeal Board in Canada issued a landmark decision, holding that an AI system is not a valid "inventor" under Canadian patent law. In the result, the patent filed by computer scientist Stephen Thaler...

G

Gilbert's LLP

Anticipation Through Incorporation By Reference Legally Permissible

G

Gilbert's LLP

Coup d'œil sur les nouvelles règles de PIO concernant le financement des services juridiques en PI pour les entreprises de l'Ontario

MT

Miller Thomson LLP

Update On Biosimilars In Canada – June 2025

Canada Healthcare

SB

Smart & Biggar

Updated PMPRB Guidelines Expected In Summer 2025 And NPDUIS Releases Ninth Edition Of The Meds Entry Watch Report

Canada Healthcare

SB

Smart & Biggar

Canadian Patent Law: A Board Assesses Patentability While The Court Assesses Validity

ML

McMillan LLP

Patents vs Trade Secrets In Canada – No, They're Not Just Alternatives

PL

Procido LLP

Inventorship And The Importance Of Invention Documentation

OW

Oyen Wiggs Green & Mutala LLP

Canadian Intellectual Property Office "Next Generation Patents" Update And Status As Of June 17, 2025

SB

Smart & Biggar

Potential Amendments To Canadian Practice On Patentable Subject-Matter For Computer-Implemented Inventions

C

Cassels

Incidence de l'IA sur le droit canadien

BC

Blake, Cassels & Graydon LLP

Patent Re-Examination Board Decision Does Not Preclude Patent Validity Challenge In Court

MT

McCarthy Tétrault LLP

Apotex Not Entitled To Damages For Delayed Generic Drug Launch

TS

Tierney Stauffer LLP

Protecting Innovation In Oil And Gas: AI, Automation And The High-Tech Frontier

BJ

Bennett Jones LLP

Alexion Awarded Injunction Against Amgen In SOLIRIS Patent Action; Court Considers Anticipation By Incorporation By Reference

SB

Smart & Biggar

Mapping The Intersection Of AI And Canadian Law

Canada Technology

BC

Blake, Cassels & Graydon LLP

See more

Latest Videos

See more

IP Explained: The Basics (Video)

FL

Field LLP

Can AI Be An Inventor On A Patent Or Author Of A Copyrighted Work?

OH

Osler, Hoskin & Harcourt LLP

The Legal Steps To Startups: What You Need To Know About Patents (Video)

PM

Parlee McLaws

Using Intellectual Property To Protect Your Company's Assets (Video)

CM

Crowe MacKay LLP

Cleantech And The Protection Of Intellectual Property (Video)

GW

Gowling WLG

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More